CellaVision AB | Cash Flow

Fiscal year is January-December. All values SEK Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
24,690.00
43,369.00
65,553.00
75,775.00
90,343.00
112,097
Depreciation, Depletion & Amortization
9,089.00
12,783.00
7,572.00
8,261.00
8,450.00
1,575
Other Funds
3,378.00
5,600.00
4,449.00
7,164.00
13,504.00
3,151
Funds from Operations
37,157.00
61,752.00
68,676.00
76,872.00
85,289.00
110,521
Changes in Working Capital
9,885.00
21,968.00
19,321.00
305.00
2,609.00
36,452
Net Operating Cash Flow
27,272.00
39,784.00
87,997.00
76,567.00
87,898.00
74,069
Capital Expenditures
11,793.00
13,738.00
9,198.00
14,201.00
29,101.00
Net Investing Cash Flow
11,793.00
13,857.00
9,355.00
15,031.00
29,693.00
Cash Dividends Paid - Total
9,541.00
11,926.00
23,852.00
35,777.00
35,777.00
Issuance/Reduction of Debt, Net
5,708.00
19,978.00
-
-
-
Net Financing Cash Flow
3,833.00
31,904.00
23,852.00
35,777.00
35,777.00
Net Change in Cash
11,646.00
5,977.00
54,790.00
25,759.00
22,092.00
Free Cash Flow
25,675.00
38,338.00
87,392.00
74,642.00
84,800.00
Exchange Rate Effect
-
-
-
-
336.00
Other Uses
-
119.00
157.00
830.00
592.00

About CellaVision AB

View Profile
Address
Mobilvägen 12
Lund SN 223 62
Sweden
Employees -
Website http://www.cellavision.com
Updated 07/08/2019
CellaVision AB engages in the development and sale of software products and hardware platforms for the healthcare sector. It provides digital solutions for the medical microscopy in hematology. The company products include analyzers, review software, competency software, and accessories.